|
SNX3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.391000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.274630E-01 |
| Normal-vs-Stage2 |
3.201000E-01 |
| Normal-vs-Stage3 |
5.101500E-03 |
| Normal-vs-Stage4 |
7.903100E-03 |
| Stage1-vs-Stage2 |
8.590300E-02 |
| Stage1-vs-Stage3 |
7.596800E-04 |
| Stage1-vs-Stage4 |
1.964380E-02 |
| Stage2-vs-Stage3 |
7.062400E-02 |
| Stage2-vs-Stage4 |
2.959600E-01 |
| Stage3-vs-Stage4 |
4.440800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.090400E-01 |
| Normal-vs-AfricanAmerican |
1.262440E-01 |
| Normal-vs-Asian |
7.075000E-01 |
| Caucasian-vs-AfricanAmerican |
3.111500E-02 |
| Caucasian-vs-Asian |
6.485600E-01 |
| AfricanAmerican-vs-Asian |
9.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.772200E-01 |
| Normal-vs-Female |
6.738000E-02 |
| Male-vs-Female |
1.067560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.939400E-01 |
| Normal-vs-Extreme_Weight |
1.496990E-01 |
| Normal-vs-Obese |
3.158400E-01 |
| Normal-vs-Extreme_Obese |
5.778000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.426200E-01 |
| Normal_Weight-vs-Obese |
6.224800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.476200E-01 |
| Extreme_Weight-vs-Obese |
3.282200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.976600E-01 |
| Obese-vs-Extreme_Obese |
3.232800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.511600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.362200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.293200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.450600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.187200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.168300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.777820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.018200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.739160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.576600E-01 |
| Normal-VS-Type2 PRCC |
1.819550E-01 |
| Normal-VS-KIRP CIMP |
2.032500E-02 |
| Normal-VS-Unclassified PRCC |
6.473800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.614400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.356900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.872400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.878200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.458800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.577100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.610000E-01 |
| Normal-vs-N1 |
9.975200E-03 |
| Normal-vs-N2 |
1.532010E-01 |
| N0-vs-N1 |
1.165690E-02 |
| N0-vs-N2 |
1.013630E-01 |
| N1-vs-N2 |
7.433600E-04 |
|
|
